胞外HMGB1在常见眼科疾病中的研究进展
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金资助项目(No.81170828,81670837); 天津市应用基础与前沿技术研究计划项目(No.15JCZDJC35300); 天津市卫计委科技攻关项目(No.14KG133)


Research progress of extracellular high mobility group box 1 in common ophthalmic diseases
Author:
Affiliation:

Fund Project:

National Natural Science Foundation of China(No.81170828,81670837); Applied Basic Research Programs of Science and Technology of Tianjin(No.15JCZDJC35300); Tianjin Health and Family Planning Communication Foundation(No.14KG133)

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    高迁移率蛋白家族(high mobility group box,HMGB)因其在电泳中的高迁移率而得名,其中对高迁移率蛋白1(high mobility group box 1,HMGB1)的研究最为深入。研究表明,胞外HMGB1作为损伤相关分子模式(damage-associated molecular pattern,DAMP)参与多种常见眼部疾病——干眼、角膜病、青光眼、葡萄膜炎、糖尿病性视网膜病变、年龄相关性黄斑变性的组织损伤修复的病理生理过程,从而对疾病的愈合产生负性影响。沉默胞外HMGB1的功能有望成为这些眼科疾病新的治疗手段。本文就胞外HMGB1在常见眼科疾病中的研究进展作一综述。

    Abstract:

    High mobility group box 1(HMGB1), which belongs to a high mobility group box that known for high mobility in electrophoresis, has been researching most intensively. Recently, researches have revealed that extracellular HMGB1, as a damage-associated molecular pattern(DAMP), is involved in the pathophysiology of tissue damage repairin a variety of common ocular diseases, namely, dry eye, keratopathy, glaucoma, uveitis, diabetic retinopathy, and age-related macular degeneration, thereby negatively affecting the healing of the disease. Silencing the function of extracellular HMGB1 is expected to be a new way for these ophthalmic diseases. This thesis reviews the research progress of extracellular HMGB1 in common ophthalmic diseases.

    参考文献
    相似文献
    引证文献
引用本文

周永莹,李轩.胞外HMGB1在常见眼科疾病中的研究进展.国际眼科杂志, 2020,20(5):813-817.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2019-07-09
  • 最后修改日期:2020-04-01
  • 录用日期:
  • 在线发布日期: 2020-04-26
  • 出版日期:
文章二维码